About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

New Drug That Turns on Hormone Tap may Help Fight Osteoporosis

by Rajashri on July 17, 2008 at 3:05 PM
Font : A-A+

 New Drug That Turns on Hormone Tap may Help Fight Osteoporosis

A potential new drug that 'opens the taps' for the release of useful hormones may trigger the growth of new bones, according to European pharmacologists. This could eventually bring relief to osteoporosis sufferers.

The researchers made a presentation on the exciting potential of the so-called negative allosteric modulators at a special symposium at The Federation of European Pharmacological Societies (EPHAR) 2008 Congress at The University of Manchester, UK, on Wednesday.

Advertisement

They said that their work focussed on the stimulation of parathyroids-tiny glands located above the thyroids that control the release of the parathyroid (PTH) hormone into the bloodstream.

When the concentration of calcium is too low in the blood's plasma, PTH is released and acts on various tissues to increase the level of calcium in the blood. This calcium then activates the calcium sensing receptor on the parathyroid cell, which then reduces PTH release.
Advertisement

The first POSITIVE allosteric modulator was recently introduced into clinical practice for treating patients displaying high levels of PTH in the plasma - such as those with chronic kidney disease on dialysis and those displaying hypercalcaemia with parathyroid cancer. It mimics the effect of calcium on the receptor and so reduces PTH release.

The researchers said that negative allosteric modulators had been found to block the effect of calcium on the parathyroid cell in pre-clinical trials, and thereby increase the release of PTH in the serum.

"Daily administration of a negative allosteric modulator of the calcium sensing receptor should promote a sustained increase of PTH in such a way that it will stimulate new bone formation," said symposium organiser Martial Ruat, a neuropharmacologist at the government funded Centre National de la Recherche Scientifique in France.

"Now clinical trials will have to demonstrate the effectiveness and suitability of negative allosteric modulators for treating osteoporosis in humans," the researcher added.

Dr. Raut also said that it might take at least another eight to 10 years before negative allosteric modulators were passed for use in patients.

"Osteoporosis is a complex disease and the timescale might be rather long," said Dr. Ruat, who is himself carrying out research to learn more about the potential benefits of both negative and positive allosteric modulators.

"The calcium sensing receptor is also found in the kidney, the intestine, in some vascular and bone cells and also in the brain. We still need to identify the roles of this receptor in these tissues before being able to specify novel applications of these drugs," he added.

European pharmacologists are studying negative and positive allosteric modulators to identify the functions of calcium sensing receptors in the control of blood pressure also.

Source: ANI
RAS/L
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Advertisement
News Category
What's New on Medindia
Black Tea Protects against Blood Pressure and Heart Diseases
Green Mediterranean Diet may Help Repair Age-Related Brain Damages
Cervical Cancer Awareness Month 2022
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Drug Toxicity Rickets Osteoporosis Lifestyle And Osteoporosis Clinical Trials - Different Phases of the trial Kyphosis Signature Drug Toxicity Colle’s Fracture 

Recommended Reading
Osteoporosis
Osteoporosis is a bone disease that leads to an increased risk of fractures. The bone mass is ......
Lifestyle And Osteoporosis
Encyclopedia section of medindia briefly explains about Lifestyle and Osteoporosis...
Calcium and Vitamin Supplements
Calcium and vitamin supplements are taken to provide the body with the ''required'' nutrients. ......
Clinical Trials - Different Phases of the trial
Clinical trials serve as a vital component for improving the treatment of medical conditions as they...
Colle’s Fracture
Colles fracture or broken wrist is a wrist fracture, which occurs within an inch of the wrist joint....
Drug Toxicity
Drug toxicity is an adverse reaction of the body towards a drug that results as a side effect of a d...
Kyphosis
Kyphosis is a spinal disorder, which is derived from Greek word – 'kyphos' which means bowed or ben...
Osteoporosis
Osteoporosis is a bone disease that leads to an increased risk of fractures. The bone mass is reduce...
Rickets
Encyclopedia section of medindia explains in brief about Rickets...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2022

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
open close
CONSULT A DOCTOR
I have read and I do accept terms of use - Telemedicine

Advantage Medindia: FREE subscription for 'Personalised Health & Wellness website with consultation' (Value Rs.300/-)